• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度南部类风湿关节炎患者的合并症及相关因素——卡纳塔克邦类风湿关节炎合并症(KRAC)研究

Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.

作者信息

Chandrashekara S, Shobha V, Dharmanand B G, Jois R, Kumar S, Mahendranath K M, Haridas V, Prasad S, Singh Y, Daware M A, Swamy A, Subramanian R, Somashekar S A, Shanthappa A M, Anupama K R

机构信息

ChanRe Rheumatology and Immunology Center, Bangalore.

出版信息

Reumatismo. 2017 Aug 3;69(2):47-58. doi: 10.4081/reumatismo.2017.898.

DOI:10.4081/reumatismo.2017.898
PMID:28776358
Abstract

The aim was to study the prevalence of comorbidities in rheumatoid arthritis (RA) patients in everyday clinical practice and their association with disease-specific and demographic factors. The multi-center study recruited 3,247 (at 14 centers, and 265) were excluded due to incomplete data. The number of subjects considered for the analysis was 2982. The mean (±standard deviation) age was 48.98±12.64 years and the male-to-female ratio was 1:5. The data was collected based on a pre-structured pro forma by trained clinical research associates through interview and verification of charts and reports available in the patient records. The following comorbidities were studied: cardiovascular disease, hypertension, diabetes mellitus, hypercholesterolemia, thyroid disease, psychiatric diseases like depression, and pulmonary disease. Hypertension (20.7%), diabetes mellitus (14.4%) and thyroid disease (18.3%) were the most prevalent comorbidities. Hypercholesterolemia (5.3%), pulmonary diseases (2.1%), cardiovascular diseases (0.2%) and depression (0.03%) were prevalent in ≤5% of the study population. The overall presence of comorbidity increased with age and reduced with the duration of illness prior (DOIP). The age, gender, and DOIP differed significantly between groups with and without hypercholesterolemia. Females had a statistically increased prevalence of thyroid disease. The prevalence of comorbidities in RA patients from south India is around 40% and the incidence of comorbidity increased with age. As per the literature evidence, the prevalence in the current study subjects was higher when compared to prevalence of similar diseases occurring in the general south Indian population.

摘要

目的是研究日常临床实践中类风湿关节炎(RA)患者合并症的患病率及其与疾病特异性因素和人口统计学因素的关联。这项多中心研究招募了3247名患者(在14个中心),其中265名因数据不完整而被排除。纳入分析的受试者数量为2982名。平均(±标准差)年龄为48.98±12.64岁,男女比例为1:5。数据由经过培训的临床研究助理根据预先构建的表格,通过访谈以及核查患者记录中的图表和报告来收集。研究了以下合并症:心血管疾病、高血压、糖尿病、高胆固醇血症、甲状腺疾病、抑郁症等精神疾病以及肺部疾病。高血压(20.7%)、糖尿病(14.4%)和甲状腺疾病(18.3%)是最常见的合并症。高胆固醇血症(5.3%)、肺部疾病(2.1%)、心血管疾病(0.2%)和抑郁症(0.03%)在≤5%的研究人群中较为常见。合并症的总体患病率随年龄增加而升高,随患病时间(DOIP)缩短而降低。有高胆固醇血症和无高胆固醇血症的组在年龄、性别和DOIP方面存在显著差异。女性甲状腺疾病的患病率在统计学上有所增加。印度南部RA患者的合并症患病率约为40%,且合并症的发生率随年龄增加而升高。根据文献证据,与印度南部普通人群中类似疾病的患病率相比,本研究受试者中的患病率更高。

相似文献

1
Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.印度南部类风湿关节炎患者的合并症及相关因素——卡纳塔克邦类风湿关节炎合并症(KRAC)研究
Reumatismo. 2017 Aug 3;69(2):47-58. doi: 10.4081/reumatismo.2017.898.
2
Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.通过有效的疾病控制降低类风湿关节炎关节外表现的发生率:卡纳塔克邦类风湿关节炎合并症(KRAC)研究。
Int J Rheum Dis. 2017 Nov;20(11):1694-1703. doi: 10.1111/1756-185X.12957. Epub 2016 Dec 10.
3
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study.影响类风湿关节炎患者缓解的因素:卡纳塔克邦类风湿关节炎合并症(KRAC)研究结果
Int J Rheum Dis. 2018 Nov;21(11):1977-1985. doi: 10.1111/1756-185X.12908. Epub 2016 Jul 25.
4
Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study.痛风和类风湿性关节炎在心血管风险管理中均需牢记:一项初级保健回顾性队列研究。
Joint Bone Spine. 2017 Jan;84(1):59-64. doi: 10.1016/j.jbspin.2015.12.003. Epub 2016 May 25.
5
Influence of disease duration and socioeconomic factors on the prevalence of infection and hospitalization in rheumatoid arthritis: KRAC study.疾病持续时间和社会经济因素对类风湿关节炎感染和住院患病率的影响:KRAC 研究。
Int J Rheum Dis. 2019 Jul;22(7):1216-1225. doi: 10.1111/1756-185X.13562. Epub 2019 Apr 11.
6
High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.基于日本健康保险数据库的一项横断面研究显示,类风湿关节炎患者心血管合并症的患病率较高。
Mod Rheumatol. 2016 Jul;26(4):522-8. doi: 10.3109/14397595.2015.1106682. Epub 2015 Dec 14.
7
[Comorbidity in rheumatoid arthritis].[类风湿关节炎中的合并症]
Dtsch Med Wochenschr. 2014 Sep;139(37):1844-8. doi: 10.1055/s-0034-1370262. Epub 2014 Sep 2.
8
Five-year incidence of common comorbidities, such as hypertension, dyslipidemia, diabetes mellitus, cardiovascular disease, cerebrovascular disease and cancer, in older Japanese patients with rheumatoid arthritis.日本老年类风湿关节炎患者常见共病(如高血压、血脂异常、糖尿病、心血管疾病、脑血管疾病和癌症)的 5 年发生率。
Geriatr Gerontol Int. 2019 Jul;19(7):577-581. doi: 10.1111/ggi.13664. Epub 2019 Apr 5.
9
Comorbidity in psoriatic arthritis and rheumatoid arthritis.银屑病关节炎和类风湿关节炎中的共病情况。
Intern Med J. 2018 Nov;48(11):1360-1368. doi: 10.1111/imj.14046.
10
Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.患有难治性类风湿关节炎患者的合并症负担和临床特征。
Clin Rheumatol. 2019 Sep;38(9):2473-2481. doi: 10.1007/s10067-019-04579-1. Epub 2019 May 10.

引用本文的文献

1
Clinical Characteristics, Medication Use, and Short-Term Outcomes in Patients With Rheumatoid Arthritis: A Prospective Observational Study at a Tertiary Care Centre in Central India.类风湿关节炎患者的临床特征、用药情况及短期结局:印度中部一家三级医疗中心的前瞻性观察研究
Cureus. 2025 May 25;17(5):e84785. doi: 10.7759/cureus.84785. eCollection 2025 May.
2
Comorbidities in Nigerian patients with rheumatoid arthritis.尼日利亚类风湿关节炎患者的合并症。
Clin Rheumatol. 2024 Jan;43(1):23-28. doi: 10.1007/s10067-023-06797-0. Epub 2023 Oct 23.
3
The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
类风湿关节炎患者心血管疾病风险预测评分的比较及亚临床动脉粥样硬化的评估:一项横断面研究。
Clin Rheumatol. 2022 Dec;41(12):3675-3686. doi: 10.1007/s10067-022-06349-y. Epub 2022 Aug 25.
4
A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Rheumatoid Arthritis (MEDRA): Study protocol.一项针对类风湿性关节炎成人患者的地中海饮食干预随机对照试验(MEDRA):研究方案。
Contemp Clin Trials Commun. 2022 May 3;28:100919. doi: 10.1016/j.conctc.2022.100919. eCollection 2022 Aug.
5
Dietary Interventions with or without Omega-3 Supplementation for the Management of Rheumatoid Arthritis: A Systematic Review.膳食干预联合或不联合ω-3 补充剂治疗类风湿关节炎的系统评价。
Nutrients. 2021 Oct 4;13(10):3506. doi: 10.3390/nu13103506.
6
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.风湿病学中使用的生物制剂的安全性概况:一项意大利前瞻性药物警戒研究。
J Clin Med. 2020 Apr 24;9(4):1227. doi: 10.3390/jcm9041227.
7
Temporomandibular Disorders and Oral Features in Early Rheumatoid Arthritis Patients: An Observational Study.颞下颌关节紊乱与早期类风湿关节炎患者的口腔特征:一项观察性研究。
Int J Med Sci. 2019 Jan 1;16(2):253-263. doi: 10.7150/ijms.28361. eCollection 2019.
8
Possible use of miRNAs-146a and -499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis.miRNAs-146a 和 -499 的表达及其多态性可能作为类风湿关节炎的诊断标志物。
Mol Cell Biochem. 2018 Dec;449(1-2):145-156. doi: 10.1007/s11010-018-3351-7. Epub 2018 Apr 26.